Ausdal Financial Partners Inc. bought a new stake in CME Group Inc. (NASDAQ:CME - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 4,023 shares of the financial services provider's stock, valued at approximately $888,000.
A number of other hedge funds have also made changes to their positions in the stock. Empowered Funds LLC increased its holdings in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider's stock valued at $2,660,000 after acquiring an additional 1,037 shares during the last quarter. Marshall Wace LLP grew its holdings in CME Group by 103.1% during the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider's stock valued at $1,018,000 after purchasing an additional 121,707 shares during the last quarter. Federated Hermes Inc. raised its position in shares of CME Group by 1,325.2% in the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider's stock valued at $6,497,000 after purchasing an additional 21,918 shares during the period. Nebula Research & Development LLC bought a new position in shares of CME Group in the second quarter valued at approximately $992,000. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider's stock worth $79,344,000 after buying an additional 7,397 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Stock Up 1.3%
Shares of CME Group stock opened at $280.98 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The business has a fifty day simple moving average of $252.32 and a 200 day simple moving average of $279.24. The stock has a market cap of $101.03 billion, a PE ratio of 23.83, a price-to-earnings-growth ratio of 3.30 and a beta of 0.23.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.08. The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company's revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the previous year, the company earned $2.96 EPS. Research analysts predict that CME Group Inc. will post 12.27 EPS for the current year.
CME Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio is presently 44.11%.
Insiders Place Their Bets
In other news, Director William R. Shepard purchased 325 shares of CME Group stock in a transaction dated Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.30% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently weighed in on CME. The Goldman Sachs Group reduced their price objective on CME Group from $267.00 to $245.00 and set a "sell" rating for the company in a research report on Tuesday, June 30th. TD Cowen dropped their target price on CME Group from $323.00 to $273.00 and set a "buy" rating for the company in a report on Monday, June 22nd. Bank of America lifted their price objective on CME Group from $226.00 to $230.00 and gave the company an "underperform" rating in a report on Thursday, July 23rd. Wall Street Zen downgraded shares of CME Group from a "sell" rating to a "strong sell" rating in a research note on Saturday, August 1st. Finally, Raymond James Financial reaffirmed an "outperform" rating and issued a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, CME Group currently has an average rating of "Hold" and a consensus price target of $288.56.
View Our Latest Stock Report on CME
About CME Group
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
